Journal of Endovascular Therapy · 2006 · 18 citations · 35 references
Life SciencesBioengineeringCell BiologyRegenerative MedicineStem Cell BiologyTissue EngineeringAnimal Cell CultureCell CultureCell Culture TechnologyStem Cell PhysiologyTissue CultureTissue Engineering With Stem CellsElectrical StimulationElectrical Stimulation ParametersMicroscopic ImagingMicroscopic ObservationProgenitor Cell DifferentiationProgenitor CellsTissue-engineered Cell CultureTissue-engineered Constructs
PURPOSE: To test the hypothesis that a level of chemical and electrical stimulation exists that allows differentiation of progenitor cells into organized contracting myocytes. METHODS: A custom-made bioreactor with the capability of delivering electrical pulses of varying field strengths, widths, and frequencies was constructed. Individual chambers of the bioreactor allowed continuous electrical stimulation of cultured cells under microscopic observation. On day 0, 1% dimethylsulfoxide (DMSO), known to differentiate cells into myocytes, was added to P19 progenitor cells. Additionally, for the next 22 days, electrical pulses of varying field strengths (0-3 V/cm), widths (2-40 ms), and frequencies (10-25 Hz) were continuously applied. On day 5, the medium containing DMSO was exchanged with regular medium, and the electrical stimulation was continued. From days 6-22, the cells were visually assessed for signs of viability, contractility, and organization. RESULTS: P19 cells remained viable with pulsed electrical fields <3 V/cm, pulse widths <40 ms, and pulse frequencies from 10 to 25 Hz. On day 12, the first spontaneous contractions were observed. For individual colonies, local synchronization and organization occurred; multiple colonies were synchronized with externally applied electrical fields. CONCLUSION: P19 progenitor cells progress to organized contracting myocytes after chemical and electrical stimulation. Incorporation of such cells into existing methods of producing endothelial cells, fibroblasts, and scaffolds may allow production of improved tissue-engineered vascular grafts.
35
Establishment in culture of pluripotential cells from mouse embryos
Martin Evans, M. H. Kaufman · Nature · 1981 · 8.6K citations
Heart Disease and Stroke Statistics—2006 Update
Thomas Thom, Nancy Haase, Wayne D. Rosamond et al. · Circulation · 2006 · 3.5K citations · Full text
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Peter Carmeliet, Yuval Dor, Jean-Marc Herbert et al. · Nature · 1998 · 2.5K citations
Functional Arteries Grown in Vitro
Laura E. Niklason, Jinming Gao, William M. Abbott et al. · Science · 1999 · 1.8K citations
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors
Jun K. Yamashita, Hiroshi Itoh, Masanori Hirashima et al. · Nature · 2000 · 1.4K citations